Theorem Clinical Research and Decision Driver Analytics Form Strategic Alliance
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics (DDA) that will integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.
“Knowing the right answers to key questions at critical decision points in the development process can make the difference between having the latest blockbuster or an expensive failure”
“The clinical studies that may prove a scientific point are really only one aspect of a successful drug or medical device development program,” said John Potthoff, president and CEO of Theorem Clinical Research. “Decision Driver Analytics’ product life cycle value analysis and exceptional economic insight help clients make high-value decisions with confidence throughout the entire development process.”
Decision Driver Analytics was founded in 2006 by Elizabeth Brooks, Ph.D., to provide accessible health economics analysis and strategies that can be used to drive key product decisions for manufacturers and developers. A recognized expert in her field, Brooks has designed numerous health economics models and market development programs. Backed by a team of specialists including health economists, epidemiologists, biostatisticians, medical writers and reimbursement experts, Brooks is known for an ability to make statistical results understandable and actionable.
“Knowing the right answers to key questions at critical decision points in the development process can make the difference between having the latest blockbuster or an expensive failure,” Potthoff said. “We believe this alliance helps drive projects for clients in ways that will achieve both regulatory and marketing success.”
About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.